We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+39.88%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.5B
AUM Growth
+$206M
Cap. Flow
+$190M
Cap. Flow %
12.66%
Top 10 Hldgs %
74.88%
Holding
48
New
2
Increased
4
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
MYND
Mynd.ai
MYND
+$216M
2
KRRO icon
Korro Bio
KRRO
+$35.4M
3
SYBX
Synlogic
SYBX
+$6.68M
4
PHAT icon
Phathom Pharmaceuticals
PHAT
+$5.89M
5
IMA
ImageneBio Inc
IMA
+$1.06M

Top Sells

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$69.1M
2
UTRS
Minerva Surgical, Inc. Common Stock
UTRS
+$5.66M
3
SRFM icon
Surf Air Mobility
SRFM
+$253K
4
EAR
Eargo, Inc. Common Stock
EAR
+$189K
5
AKTX
Akari Therapeutics
AKTX
+$89.3K

Sector Composition

Rank Sector Weight
1 Healthcare 78.01%
2 Consumer Staples 16.61%
3 Technology 3.31%
4 Industrials 1.81%
5 Communication Services 0.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COUR icon
1
Coursera
COUR
$1.78B
$249M 16.61%
12,867,769
– –
ACLX
2
DELISTED
Arcellx
ACLX
$208M 13.85%
3,745,262
– –
RYTM icon
3
Rhythm Pharmaceuticals
RYTM
$7.4B
$134M 8.92%
2,909,956
– –
SVRA icon
4
Savara
SVRA
$1.09B
$115M 7.67%
24,471,264
– –
VRNA
5
DELISTED
Verona Pharma
VRNA
$111M 7.4%
5,108,563
– –
CRSP icon
6
CRISPR Therapeutics
CRSP
$4.7B
$99.4M 6.62%
1,587,854
– –
CVRX icon
7
CVRx
CVRX
$134M
$74.5M 4.97%
2,370,542
– –
GERN icon
8
Geron
GERN
$924M
$48.1M 3.2%
22,776,409
– –
GLUE icon
9
Monte Rosa Therapeutics
GLUE
$1.85B
$43.5M 2.9%
7,692,298
– –
KRRO icon
10
Korro Bio
KRRO
$148M
$41.1M 2.74%
+1,072,936
New +$35.4M
NN icon
11
NextNav
NN
$1.79B
$36.4M 2.43%
8,189,156
– –
AUPH icon
12
Aurinia Pharmaceuticals
AUPH
$1.96B
$35.7M 2.38%
3,969,834
– –
NKTX icon
13
Nkarta
NKTX
$153M
$23.6M 1.57%
3,568,781
– –
NEUE
14
DELISTED
NeueHealth
NEUE
$19.9M 1.32%
2,726,917
– –
SGMT icon
15
Sagimet Biosciences
SGMT
$442M
$18.8M 1.25%
3,850,275
– –
CELC icon
16
Celcuity
CELC
$4.07B
$18.2M 1.21%
1,250,001
– –
PHAT icon
17
Phathom Pharmaceuticals
PHAT
$943M
$17.9M 1.19%
1,960,169
+683,574
+54% +$5.89M
ALLK
18
DELISTED
Allakos
ALLK
$16.8M 1.12%
6,147,260
– –
ZFOX
19
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
$15.7M 1.05%
18,068,513
– –
TRVI icon
20
Trevi Therapeutics
TRVI
$2.59B
$15.2M 1.02%
11,370,376
– –
GOSS icon
21
Gossamer Bio
GOSS
$95.9M
$14.5M 0.96%
15,838,009
+110,067
+0.7% +$81.3K
ADAP
22
DELISTED
Adaptimmune Therapeutics
ADAP
$13.5M 0.9%
17,079,778
– –
XFOR icon
23
X4 Pharmaceuticals
XFOR
$381M
$12.6M 0.84%
499,560
– –
BDTX icon
24
Black Diamond Therapeutics
BDTX
$98M
$12.5M 0.83%
4,448,757
– –
TUYA
25
Tuya Inc
TUYA
$1.05B
$11.3M 0.76%
4,934,640
– –
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.76B AUM 13.06% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return

NEA Management Company's Q4 2023 Portfolio in Review

As of Q4 2023, NEA Management Company held 48 positions worth $1.5B, up 16% from $1.29B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

NEA Management Company deployed $190M of net new capital in Q4 2023, opening 2 new positions and adding to 4 existing holdings. Its largest new stake was Mynd.ai: 23,642,711 shares worth $1.82M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 74% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Surf Air Mobility, an estimated $253K trimmed.

  • NEA Management Company's largest Q4 2023 buy was Mynd.ai: 23,642,711 shares worth $1.82M.
  • NEA Management Company added most to Synlogic in Q4 2023, an estimated $6.68M increase.
  • NEA Management Company's biggest Q4 2023 reduction was Surf Air Mobility, cutting an estimated $253K.
  • NEA Management Company fully exited Mirum Pharmaceuticals in Q4 2023, selling an estimated $69.1M.
  • NEA Management Company's ten largest holdings make up 75% of its $1.5B portfolio in Q4 2023.
  • NEA Management Company opened 2 new positions and closed 4 in Q4 2023.
  • NEA Management Company's portfolio value rose 16% quarter-over-quarter to $1.5B.

Based on NEA Management Company's 13F filing for Q4 2023, filed 14 Feb 2024.